DATASHEET
Host:
Rabbit
Target Protein:
MYRF/C11orf9
Immunogen Range:
401-500/1151
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
745
Swiss Prot:
Q9Y2G1
Source:
KLH conjugated synthetic peptide derived from human MYRF
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
Myelin regulatory factor: Consitutes a precursor of the transcription factor. Mediates the autocatalytic cleavage that releases the Myelin regulatory factor, N-terminal component that specifically activates transcription of central nervous system (CNS) myelin genes (PubMed:23966832). Myelin regulatory factor, C-terminal: Membrane-bound part that has no transcription factor activity and remains attached to the endoplasmic reticulum membrane following cleavage. Myelin regulatory factor, N-terminal: Transcription factor that specifically activates expression of myelin genes such as MBP, MOG, MAG and PLP1 during oligodendrocyte (OL) maturation, thereby playing a central role in oligodendrocyte maturation and CNS myelination. Specifically recognizes and binds DNA sequence 5'-CTGGYAC-3' in the regulatory regions of myelin-specific genes and directly activates their expression. Not only required during oligodendrocyte differentiation but is also required on an ongoing basis for the maintenance of expression of myelin genes and for the maintenance of a mature, viable oligodendrocyte phenotype (PubMed:23966832).
PRODUCT SPECIFIC PUBLICATIONS
- Xiaowei Yu. et al. Nanophthalmos-Associated MYRF Gene Mutation Causes Ciliary Zonule Defects in Mice. Invest Ophth Vis Sci. 2021 Mar;62(3):1-1Read more>>
VALIDATION IMAGES
Formalin-fixed and paraffin embedded rat brain labeled with Anti-MRF/C11orf9 Polyclonal Antibody, Unconjugated (bs-11191R) at 1:200 followed by conjugation to the secondary antibody and DAB staining
Mouse brain lysate probed with Rabbit Anti-MRF/C11orf9 Polyclonal Antibody, Unconjugated (bs-11191R) at 1:200 overnight at 4˚C. Followed by conjugation to secondary antibody (bs-0295G-HRP) at 1:3000 for 90 min at RT. Predicted band 124kD. Observed band size: 124kD
Lane 1: Human A549 cell lysates; Lane 2: Human HepG2 cell lysates; Lane 3: Human U2OS cell; Lane 4: Human A431 cell lysates; lysates probed with MRF/C11orf9 Polyclonal Antibody, Unconjugated (bs-11191R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.